| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |